Δ133p53/FLp53 Predicts Poor Clinical Outcome in Esophageal Squamous Cell Carcinoma

BACKGROUND: p53 isoform Δ133p53 is directly transactivated by p53 and antagonizes p53 activities in cancer progression. However, its correlation with prognosis and cancer recurrence in esophageal squamous cell carcinoma (ESCC) is still unclear. PATIENTS AND METHODS: Expression of Δ133p53 and Δ133p53...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Qimin, Gong, Hongjian, Yuan, Chunhui, Liu, Gao, Huang, Jinqi, Li, Zhichao, Luo, Jianfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443442/
https://www.ncbi.nlm.nih.gov/pubmed/32884352
http://dx.doi.org/10.2147/CMAR.S263559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443442/
https://www.ncbi.nlm.nih.gov/pubmed/32884352
http://dx.doi.org/10.2147/CMAR.S263559

Ejemplares similares